Search for: "Pharmaceutical Associates, Inc." Results 201 - 220 of 1,891
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jul 2012, 10:02 pm by Linda Moss
The Associated Press Wednesday did a rather dire story on almost-complete studies on three potential drugs for Alzheimer’s disease. [read post]
2 Oct 2010, 8:43 am by Peter Rost
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales.CLIENT LIST• SPEECHES (not complete list): National Venture Capital Association, U.S. [read post]
15 Feb 2012, 7:42 am by Peter Rost
CLIENT LIST• SPEECHES (not complete list): National Venture Capital Association, U.S. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
CLIENT LIST• SPEECHES (not complete list): National Venture Capital Association, U.S. [read post]
11 Feb 2011, 7:51 am by Peter Rost
CLIENT LIST• SPEECHES (not complete list): National Venture Capital Association, U.S. [read post]
30 May 2012, 1:37 pm by Peter Rost
CLIENT LIST• SPEECHES (not complete list): National Venture Capital Association, U.S. [read post]
28 Sep 2012, 11:15 am by Todd M. Nosher
Watson Pharmaceuticals, Inc., No. 10-12729, where the Eleventh Circuit upheld reverse payments -- finding no antitrust violation in settlements involving generic Androgel. [read post]
11 Jul 2008, 4:08 am
Unlike conventional pharmaceuticals that are... [read post]
15 Jan 2014, 5:43 am by Robert Kreisman
Herndon of the Southern District of Illinois has ordered that Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
4 Feb 2013, 2:23 am by John L. Welch
Troy Newman, Cancellation No. 92047809 [Petition for cancellation of a registration for OPERATION RESCUE for "Educational services, namely, providing classes, workshops, seminars and personal instruction in the field of pro-life issues and social activism," on the ground that the mark falsely suggests an association with Petitioner Terry, under Section 2(a)].February 19, 2013 - 10 AM: Glen Raven, Inc. v. [read post]
4 Nov 2013, 3:04 am by Ben Vernia
On November 4, the Department of Justice announced that Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc., and Scios, Inc., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
15 Mar 2013, 6:00 am by Michael B. Stack
“Wholesale pharmacies who contract with physicians to provide pharmaceuticals to them on a consignment basis for dispensing to their workers compensation patients, cannot seek payment for the pharmaceuticals directly from the employer/insurer underRebel Distributors Corp., Inc. d/b/a Physician Partner and Pharmacy Partner v. [read post]
9 Dec 2013, 7:01 am by Lyle Denniston
In association with Bloomberg Law [read post]